SCHEMBL8566405

SCHEMBL8566405

CN1CCN(c2ncnc(Cl)c2Sc2ccccc2Cl)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.50
CYP3A4 P08684 2/20 0.50
CYP2D6 P10635 2/20 0.50
HSD17B10 Q99714 2/20 0.50
CYP2C19 P33261 2/20 0.47
USP2 O75604 1/20 0.47
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
TSHR P16473 1/20 0.47
MAPK1 P28482 1/20 0.47
HIF1A Q16665 1/20 0.47
CLK4 Q9HAZ1 1/20 0.47
CNR2 P34972 1/20 0.47
HRH4 Q9H3N8 5/20 0.47
DRD2 P14416 6/20 0.46
HTR1A P08908 5/20 0.46
DRD4 P21917 3/20 0.46
HTR3B O95264 1/20 0.45
HTR3A P46098 1/20 0.45
ALOX15 P16050 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8569210 0.84 HTR1A (0.62) CYP1A2CYP3A4CYP2D6HSD17B10CYP2C19
SCHEMBL8565869 0.79 HTR1A (0.67) CYP1A2CYP3A4CYP2D6HSD17B10HRH4
SCHEMBL8564814 0.77 MAPT (0.45) ALDH1A1LMNATSHRHTT
SCHEMBL11952724 0.74 HRH4 (0.52) CYP1A2CYP3A4CYP2D6HSD17B10CYP2C19
SCHEMBL26647139 0.72 HTT (0.56) CYP1A2CYP3A4CYP2D6HSD17B10CYP2C19
SCHEMBL30828999 0.72 HTT (0.56) CYP1A2CYP3A4CYP2D6HSD17B10CYP2C19
SCHEMBL13722300 0.67 HSD11B1 (0.57) CYP1A2CYP3A4CYP2D6HSD17B10HRH4
SCHEMBL12844776 0.64 HRH4 (1.00) CYP1A2CYP3A4CYP2D6HSD17B10CYP2C19
SCHEMBL424507 0.63 DRD2 (0.75) ALDH1A1LMNAMAPK1HRH4DRD2
SCHEMBL14046598 0.63 HRH4 (0.56) CYP1A2CYP3A4CYP2D6HSD17B10CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0826674-A1 NOVEL PYRIMIDINE DERIVATIVES EFFICACIOUS AS PSYCHOTROPIC DRUG AND PROCESS FOR THE PRODUCTION THEREOF SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1998-03-04 EP disclosed